Claire Levy talks with Dr Shivani Misra who’s been working with DRWF for over ten years, and has now joined the board of trustees. Her research has been investigating various aspects of genetic forms of diabetes in minority ethnic groups, and subsequently the identification of MODY - maturity onset diabetes of the young - in multi-ethnic populations.
In this edition, we’re looking at the impact of DRWF’s research funding in stimulating vital early development of new treatments and therapies. We’ve been talking to researchers who have gone on to win major funding under the Grand Challenge, a project funded by a £50 million donation from the Steve Morgan Foundation aimed at improving the lives of people with Type 1 diabetes.
Today we’re looking at the use of continuous glucose monitoring devices (CGMs) for both type 1 and type 2 diabetes. Claire Levy talks with Jake Leach, the chief operating officer of CGM developer and manufacturer Dexcom, from their US headquarters in San Diego, California.
